Comparison of Activated Partial Thromboplastin Time (aPTT) and Anti-Factor Xa for Low Intensity Unfractionated Heparin Monitoring in Patients with Mechanical Circulatory Support Devices (MCSD)

被引:0
|
作者
Volod, O. [1 ]
Lam, L. D. [2 ]
Barglowski, M. [1 ]
Mirocha, J. [3 ]
Runyan, C. [2 ]
Moriguchi, J. [4 ]
Czer, L. S. [4 ]
Arabia, F. [5 ]
机构
[1] Cedars Sinai Med Ctr, Pathol, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, Cedars Sinai Res Inst, Los Angeles, CA 90048 USA
[4] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA
[5] Cedars Sinai Med Ctr, Ctr Surg Device Management, Los Angeles, CA 90048 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1356
引用
收藏
页码:S443 / S443
页数:1
相关论文
共 50 条
  • [1] Anti-Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support
    Adatya, Sirtaz
    Uriel, Nir
    Yarmohammadi, Hirad
    Holley, Christopher T.
    Feng, Amy
    Roy, Samit S.
    Reding, Mark T.
    John, Ranjit
    Eckman, Peter
    Zantek, Nicole D.
    [J]. JACC-HEART FAILURE, 2015, 3 (04) : 314 - 322
  • [2] SAFETY OF MONITORING UNFRACTIONATED HEPARIN INFUSIONS IN CRITICALLY ILL PATIENTS: ANTI-FACTOR XA VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
    Burka, Abigail
    Cunningham, Michael
    Ernst, Neil
    Droege, Chris
    Hillebrand, Kristen
    Clark, Lindsey
    Tsuei, Betty
    Mueller, Eric
    [J]. CRITICAL CARE MEDICINE, 2012, 40 (12) : U279 - U279
  • [3] Comparing Anti-Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly W.
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (08) : 801 - 805
  • [4] Comparing anti-factor Xa and activated partial thromboplastin levels for monitoring unfractionated heparin.
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly
    [J]. PHARMACOTHERAPY, 2018, 38 (07): : E54 - E54
  • [5] Interlaboratory Precision in the Monitoring of Unfractionated Heparin Using the Anti-Factor Xa-Correlated Activated Partial Thromboplastin Time
    Cuker, Adam
    Ptashkin, Beverly
    Konkle, Barbara A.
    Pipe, Steven W.
    Whinna, Herbert C.
    Zheng, X. Long
    Cines, Douglas B.
    Pollak, Eleanor
    [J]. BLOOD, 2008, 112 (11) : 166 - 166
  • [6] ANTI-FACTOR XA VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR HEPARIN INFUSION MONITORING
    Jung, Sul
    Choi, Austin
    Lepore, Mark
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [7] Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time
    Cuker, A.
    Ptashkin, B.
    Konkle, B. A.
    Pipe, S. W.
    Whinna, H. C.
    Zheng, X. L.
    Cines, D. B.
    Pollak, E. S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (01) : 80 - 86
  • [8] Determining Cause for Activated Partial Thromboplastin Time and Anti-Factor Xa Discordance in Mechanical Circulatory Support Patients on Heparin; Can Thromboelastogram Help?
    Volod, O.
    Lam, L.
    Robert, C.
    Moriguchi, J.
    Yur, J.
    Garcia, M.
    Zhou, J.
    Wilde, A.
    Czer, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S463 - S463
  • [9] Anti-factor Xa Levels Versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin in Patients with Continuous Flow Left Ventricular Assist Devices
    Yarmohammadi, H.
    Holley, C.
    Thennapin, T.
    Duval, S.
    Pritzker, M.
    Cogswell, R.
    John, R.
    Colvin-Adams, M.
    Eckman, P.
    Adatya, S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S23 - S24
  • [10] Components of variability of activated partial thromboplastin time (APTT) vs. anti-factor Xa (AXa) on unfractionated heparin (UFH) dose adjustments
    Guerrero, F.
    Faure, A.
    Diemert, V
    Voisin, S.
    Sie, P.
    Riviere, Bura A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 683 - 684